On Apr. 24, 2023, Boehringer Ingelheim inaugurated its state-of-the-art Biologicals Development Center in Biberach an der Ri�, Germany. With an investment of 350 million EUR, Boehringer Ingelheim significantly enhanced its innovation power and development of biopharmaceutical development capabilities in Germany.